420 related articles for article (PubMed ID: 37335014)
1. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.
Xiao Y; Powell DW; Liu X; Li Q
Am J Physiol Regul Integr Comp Physiol; 2023 Aug; 325(2):R193-R211. PubMed ID: 37335014
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Inflammatory Bowel Disease and Its Complications.
Krishnachaitanya SS; Liu M; Fujise K; Li Q
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955886
[TBL] [Abstract][Full Text] [Related]
3. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira-Junior R; Figueredo CM
World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
[TBL] [Abstract][Full Text] [Related]
4. Extraintestinal manifestations of inflammatory bowel disease.
Urlep D; Mamula P; Baldassano R
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement in paediatric inflammatory bowel disease.
Mutalib M
Pediatr Nephrol; 2021 Feb; 36(2):279-285. PubMed ID: 31820145
[TBL] [Abstract][Full Text] [Related]
6. The Gut-Immune-Brain Axis: An Important Route for Neuropsychiatric Morbidity in Inflammatory Bowel Disease.
Masanetz RK; Winkler J; Winner B; Günther C; Süß P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232412
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease and the risk of cardiovascular diseases.
Nuñez P; García Mateo S; Quera R; Gomollón F
Gastroenterol Hepatol; 2021 Mar; 44(3):236-242. PubMed ID: 33223261
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory bowel diseases and upper gastrointestinal tract].
Chatelain D; Moslemi A; Dreau A; Clement M
Ann Pathol; 2023 Jun; 43(3):192-201. PubMed ID: 36822896
[TBL] [Abstract][Full Text] [Related]
9. Risks of Cardiovascular Events in Patients With Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
Fang L; Gao H; Gao X; Wu W; Miao Y; Zhang H; Guleng B; Zhang H; Wang Y; Li M; Yang H; Gao X; Liang J; Cao Q; Shen J; Ran Z; Wu K; Qian J; Chen M; Liu Z
Inflamm Bowel Dis; 2022 Jun; 28(Supple 2):S52-S58. PubMed ID: 34969082
[TBL] [Abstract][Full Text] [Related]
10. Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
Zhang C; Liu X
Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102214. PubMed ID: 37748580
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
12. [Extraintestinal manifestations in chronic inflammatory bowel diseases].
Vavricka SR; Greuter T; Zeitz J
Ther Umsch; 2019 Jan; 75(5):281-285. PubMed ID: 30700241
[TBL] [Abstract][Full Text] [Related]
13. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
14. [Extraintestinal manifestations in inflammatory bowel disease].
Vavricka SR
Ther Umsch; 2023 Dec; 80(9):393-397. PubMed ID: 38095252
[TBL] [Abstract][Full Text] [Related]
15. Neurology of inflammatory bowel disease.
Ferro JM; Oliveira Santos M
J Neurol Sci; 2021 May; 424():117426. PubMed ID: 33810878
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
Kul S; Caliskan Z; Guvenc TS; Celik FB; Sarmis A; Atici A; Konal O; Akıl M; Cumen AS; Bilgic NM; Yilmaz Y; Caliskan M
Microvasc Res; 2023 Mar; 146():104458. PubMed ID: 36471530
[TBL] [Abstract][Full Text] [Related]
17. Dermatologic manifestations of inflammatory bowel disease: a review.
Keyal U; Liu Y; Bhatta AK
Discov Med; 2018 May; 25(139):225-233. PubMed ID: 29906405
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Montenegro ML; Corral JE; Lukens FJ; Ji B; Kröner PT; Farraye FA; Bi Y
Dig Dis Sci; 2022 Feb; 67(2):423-436. PubMed ID: 33625614
[TBL] [Abstract][Full Text] [Related]
19. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
